Moodmon is a

n

clinically tested

innovative

AI-based

system that improves the life of mentally disordered patients and their families as well as supports psychiatrists in the process of treatment.

What is Moodmon?

Moodmon is an AI based system supporting therapy of affective disorders.

Monitoring

Currently, Moodmon supports the monitoring of the present state of patients diagnosed with bipolar disorder or depression.

Predictions

Our individual and generic AI models predict possibly dangerous mood changes on the basis of data collected from mobile phones and digital wristbands.

Alerts

Moodmon alerts the patient, the psychiatrist and authorised relatives. The alerts grant faster reaction and better treatment results.

How it works?

Moodmon uses data collected from wearables (mobile phone and wristband) as well as data retrieved from a web app used by the physician to feed AI models predicting possible behaviour changes.
Major advantage of Moodmon is the usage of individual AI models per patient and continuous re-training of models to account for changes not related to the disease.

Moodmon addresses most significant problems faced by different stakeholder groups

A sense of lack of control over their lives due to constant dependence on mood changes. Frequent and irritating questions about their mental state.

Limited access to psychiatrists and difficulties in relating objectively all the past events to be reported to the doctor.

Remembering appointment dates and medication times. Monitoring their condition and informing relatives about their well-being.

Stress, which relatives try to relieve by constant analysis of behaviour and being overprotective.

Deterioration of relationships with the disordered relative caused by disbelief about their declared mental state and being overburdened with responsibility.

The difficulties in patient monitoring forces relatives to allocate more time and financial resources in the treatment process than is actually necessary.

Uncertainty of the diagnosis and medication results due to subjective information provided by patients.

Difficulties to timely adjust medication between regular appointments.

Insufficient and sporadic contact with patients.

How do we help?

Over 10% of the global population suffers from chronic affective disorders. During remission periods patients are valuable members of the society, but relapses destroy their lives both on the professional and personal level. Up to 15% of victims commit successfull suicide. Early prevention of the relapse development allows the patient to avoid hospitalisation and minimises adverse impact on every aspect of life. However, early detection is possible only by close monitoring of the patient and this is what Moodmon offers to patients and their care-takers. We make life easier to endure and save lives threatened by desperation.

Other advantages

Additional communication channel between the patient and the doctor

Notifications for the patient about upcoming visits

Reminders about medication times and dosis

Continuous data gathering for the psychiatrists to improve therapy efficiency and diagnosis accuracy

Data presentation for the patient

Valuable database for scientific investigation in the area of psychiatry and behavioural sciences

The system is characterised by

Objectivity
and reliability

Analysis of behavioural and physiological data, clinically tested, used under medical supervision

Ease of use and accessibility

Cell phone, Internet, data gathered without patient involvement

Flexibility and personalization

Continuous re-training, individual AI models

Privacy

Anonymization, without content analysis

Growth Plan

The idea started in 2015 and originated in the environment of relatives of bipolar patients. With support from a business angel (Britenet company) and European funding, the first POC was launched in 2017.

2021-2023

* Design and development
* Clinical testing of the monitoring system